Figure 5.
Schematic representation of how IFN-γ may affect IDO expression through modulation of IRF-8 and DAP12. In murine and human DCs, IFN-γ will act on IRF-8 to enhance IDO and to decrease DAP12, which basally opposes IDO expression. Also depicted are the activating receptors typically associated with DAP12 in DCs.